
Site burden is now measured through satisfaction surveys, in-the-moment check-ins, and adoption patterns, but each method catches a different moment, and the gaps between them decide whether teams can act before burden becomes risk.
ERT-a global data and technology company tht minimizes uncertainty and risk in clinical trials-announced its acquisition of Biomedical Systems-a provider of imaging and cardiac safety and respiratory data collection solutions.
Read the full release






